In an 18-patient single-center study of untreated essential hypertension, 12 patients used a hypertension-support app and 6 served as controls. Office systolic pressure fell comparably in both arms (DTx 144.0 to 128.0 mmHg at 12 months; control 149.0 to 132.5), so the primary outcome showed no between-group difference. Estimated salt intake dropped from 8.8 to 7.0 g/day with the app but stayed near 9.3-9.6 g/day in controls, and the improved urinary sodium-to-potassium ratio persisted only in the app group.

The dissociation between diet and blood pressure is the real story. Sodium reduction and a lower sodium-to-potassium ratio are among the best-supported levers for lowering blood pressure, and a sustained 1.8 g/day cut would normally predict a few mmHg of added benefit. The absent difference most likely reflects the design rather than a failed mechanism: six controls cannot detect a modest effect, and both groups dropped roughly 16 mmHg, a pattern typical of regression to the mean, white-coat effects and the attention that comes with enrollment. Control patients likely changed behavior too, even though their measured salt intake did not move, and spot-urine salt estimates are noisy.

What this adds is a feasibility signal, not evidence of efficacy. Keeping dietary change going past six months is where most lifestyle programs fail, and an app that holds it for a year is worth testing in adequately powered randomized trials with 24-hour urine collection and ambulatory blood pressure. Treat it as hypothesis-generating and incremental. Adults with mild hypertension can reasonably pursue salt reduction now, with or without an app.